Systematic review and comment on modern study of Xiaojin Pills.
10.19540/j.cnki.cjcmm.20181105.006
- Author:
Xi XIONG
1
;
Bi FENG
1
;
Bo CAO
1
;
Ding-Kun ZHANG
1
;
Kai-Peng XIONG
2
;
Jun-Zhi LIN
3
;
Zhi-Min CI
1
;
Run-Chun XU
1
;
Li HAN
1
Author Information
1. State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
2. Chengdu Jiuzhitang Jinding Pharmaceutical Co., Ltd., Chengdu 610051, China.
3. Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China.
- Publication Type:Journal Article
- Keywords:
Xiaojin Pills;
chemical components;
clinical application;
particle design;
pharmacological action;
quality control
- MeSH:
Capsules;
Drugs, Chinese Herbal;
Quality Control;
Research
- From:
China Journal of Chinese Materia Medica
2018;43(24):4801-4807
- CountryChina
- Language:Chinese
-
Abstract:
Xiaojin Pill, was firstly recorded in Life-saving Manual of Diagnosis and Treatment of External Diseases, with its primitive name of "Xiaojin Dan". Xiaojin Pill is a classic prescription for treating carbuncle and it is the first choice for Chinese medicine in the clinical treatment of hyperplasia of mammary glands. In this paper, the literature reports on Xiaojin Pills were summarized and the historical evolution, material basis, pharmacological action, quality control and other problems were systematically discussed to explore the potential problems in every aspect of the development status, and put forward the development countermeasures, providing reference for the modernization research and development of Xiaojin Pills.
